Logo Image
NEWS
Special ReportsAll NewsFDA BriefsOncology IconsThe Targeted Pulse
CONFERENCES
Conference CoverageConference ListingData Dialogue with the Oncology Brothers
MEDIA
All VideosCase-Based Peer PerspectivesEvolving Paradigms in OncologyExpert Perspective Virtual Tumor BoardInterviewsInvestigator PerspectivesMedical World NewsPivotal Practice Views with the Oncology BrothersPodcastsPractice PlaybookShortsVideo Series
PUBLICATIONS
All PublicationsEvolving ParadigmsPeers & Perspectives in OncologyTargeted Therapies in Oncology
More
CASE-BASED ROUNDTABLE
PARTNERS
RESOURCES
CME/CEClinical TrialsEventsPrecision Medicine PerspectivesPress ReleasesSponsored ContentTreatment Resources
SUBSCRIBE
  • NEWS
  • CONFERENCES
  • MEDIA
  • PUBLICATIONS
  • CASE-BASED ROUNDTABLE
  • PARTNERS
  • RESOURCES
  • SUBSCRIBE
  • BRAIN CANCER
  • BREAST CANCER
    • HER2 Breast Cancer
  • COMMUNITY ONCOLOGY PRACTICE
  • GENITOURINARY CANCERS
    • Bladder Cancer
    • Prostate Cancer
    • Renal Cell Carcinoma
  • GENOMIC TESTING
    • Liquid Biopsies
  • GI CANCERS
    • Pancreatic Cancer
    • Colorectal Cancer
    • Gastric Cancer
    • GIST
    • HCC
  • GYNECOLOGIC CANCERS
    • Cervical Cancer
    • Endometrial Cancer
    • Ovarian Cancer
  • HEAD & NECK CANCERS
  • HEMATOLOGY
    • Bone Marrow & Stem Cell Transplant
  • IMMUNOTHERAPY
    • CAR T-Cell Therapy
  • LEUKEMIAS
    • AML
    • Chronic Lymphocytic Leukemia
    • Chronic Myeloid Leukemia
  • LUNG CANCER
    • MET-Targeted Therapy
    • Small Cell Lung Cancer
    • Biomarker-Driven Lung Cancer
    • EGFR+ Lung Cancer
  • LYMPHOMAS
    • DLBCL
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
  • MPNs
  • MULTIPLE MYELOMA
  • NTRK GENE FUSIONS
  • ONCOLOGY POLICY
  • SARCOMA
  • SKIN CANCERS
    • Melanoma
  • THYROID CANCERS
Spotlight -
Community Oncology Practice|
Oncology Policy|
Myeloma|
CLL|
Genomic Testing|
GU Cancers
Advertisement

Metastatic Prostate Cancer with Charles Ryan, MD and William K. Oh, MD: Case 1

EP. 1: Charles Ryan, MD: Biggest Considerations for Elderly Patient Population

July 13th 2016

EP. 2: William Oh, MD: Biggest Considerations for Elderly Patient Population

July 13th 2016

EP. 3: Charles Ryan, MD: Treatment Options and Favorable Approaches for an Elderly Patient

July 13th 2016

EP. 4: Charles Ryan, MD: The Differences in Side Effects Between the Two AR-Targeted Therapies

July 13th 2016

EP. 5: Charles Ryan, MD: The Efficacy of Abiraterone Plus Prednisone in an Elderly Patient Population

July 13th 2016

EP. 6: Charles Ryan, MD: The Side Effects for Prednisone in Combination With Abiraterone

July 13th 2016

EP. 7: William Oh, MD: Ideal Treatment Options and Favorable Approaches

July 13th 2016

EP. 8: William Oh, MD: Differences Between Side Effects of AR-Targeted Therapies

July 13th 2016

EP. 9: William Oh, MD: The Efficacy of Abiraterone Plus Prednisone in an Elderly Patient Population

July 13th 2016

EP. 10: William Oh, MD: The Side Effects of Prednisone in Combination with Abiraterone

July 13th 2016
Advertisement
Advertisement

Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

1

ASCO 2026 GU Cancer Highlights: Beyond the LBAs

2

Dr Cloughesy on Extended Follow-Up Data for Vorasidenib in IDH1/2 Mutant Glioma

3

Bispecific ADC Iza-Bren Extends Survival in Advanced TNBC

4

FDA Approves Generic Eribulin Mesylate for Metastatic Breast Cancer

5

FDA Grants Priority Review to Giredestrant for ER+/HER2- Breast Cancer

  • About Us
  • Advertise
  • Contact Us
  • CureToday.com
  • CancerNetwork.com
  • OncLive.com
  • OncNursingNews.com
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
  • Editorial Board
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us